Maternal, umbilical arterial and umbilical venous 25-hydroxyvitamin D and adipocytokine concentrations in pregnancies with and without gestational diabetes

Clinical Endocrinology

Volumn 80, Issue 5, 2014, Pages 635-641

  McManus, Ruth ^a   Summers, Kelly ^a   De Vrijer, Barbra ^a   Cohen, Nicole ^a   Thompson, Alexandra ^b   Giroux, Isabelle ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b BRESCIA UNIVERSITY COLLEGE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADIPOCYTOKINE; ADIPONECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL BLOOD; MATERNAL SERUM SCREENING TEST; PLACENTA WEIGHT; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; CHEMISTRY; INFLAMMATION; PREGNANCY OUTCOME; UMBILICAL ARTERY; UMBILICAL VEIN;

ADIPOKINES; ADIPONECTIN; ADULT; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; INFLAMMATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY; PREGNANCY OUTCOME; RESISTIN; UMBILICAL ARTERIES; UMBILICAL VEINS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84898549756     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12325     Document Type: Article

References (35)

1. Buchanan, T.A., &, Xiang, A.H., (2005) Gestational diabetes mellitus. Journal of Clinical Investigation, 115, 485-491.
2. Soheilykhah, S., Mojibian, M., Rashidi, M., et al,. (2010) Maternal Vitamin D status in gestational diabetes mellitus. Nutrition in Clinical Practice, 25, 524-527.
3. Zhang, C., Qiu, C., Hu, F.B., et al,. (2008) Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS ONE, 3, e3753.
4. Kinalski, M., Telejko, B., Kuzmicki, M., et al,. (2005) Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Hormone and Metabolic Research, 37, 450-454.
5. Kuzmicki, M., Telejko, B., Szamatowicz, J., et al,. (2009) High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecological Endocrinology, 25, 258-263.
6. Flores, M., (2005) A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus? Nutrition Research Reviews, 18, 175-182.
7. Thorand, B., Zierer, A., Huth, C., et al,. (2011) Effect of serum 25-hydroxyvitamin D on risk for type diabetes may be partially mediated by subclinical inflammation. Diabetes Care, 34, 2320-2322.
8. Pittas, A.G., Joseph, N.A., &, Greenberg, A.S., (2004) Adipocytokines and insulin resistance. Journal of Clinical Endocrinology and Metabolism, 89, 447-452.
9. Galic, S., Oakhill, J.S., &, Steinberg, G.R., (2010) Adipose tissue as an endocrine organ. Molecular and Cellular Endocrinology, 316, 129-139.
10. Guzik, T.J., Mangalat, D., &, Korbut, R., (2006) Adipocytokines-novel link between inflammation and vascular function? Journal of Physiology and Pharmacology, 57, 505-528.
11. Koerner, A., Kratzsch, J., &, Kiess, W., (2005) Adipocytokines: leptin-the classical, resistin-the controversial, adiponectin-the promising, and more to come. Best Practice and Research. Clinical Endocrinology Metabolism, 19, 525-546.
12. Ortega-Senovilla, H., Schaefer-Graf, U., Meitzner, K., et al,. (2011) Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care, 34, 2061-2066.
13. Cortelazzi, D., Corbetta, S., Ronzoni, S., et al,. (2007) Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clinical Endocrinology, 66, 447-453.
14. Gueuvoghlanian-Silva, B.Y., Torloni, M.R., Mattar, R., et al,. (2012) Profile of inflammatory mediators in gestational diabetes mellitus: phenotype and genotype. American Journal of Reproductive Immunology, 67, 241-250.
15. Brochu-Gaudreau, K., Rehfeldt, C., Blouin, R., et al,. (2010) Adiponectin action from head to toe. Endocrine, 37, 11-32.
16. Cui, J., Panse, S., &, Falkner, B., (2011) The role of adiponectin in metabolic and vascular disease: a review. Clinical Nephrology, 75, 26-33.
17. http://ods.od.nih.gov/factsheets/VitaminD-HealthProfessonal/
18. Gagnon, C., Lu, Z.X., Magliano, D.J., et al,. (2011) Serum 25-hydroxyvitamin D, calcium intake, and risk for type 2 diabetes after 5 years. Diabetes Care, 34, 1133-1138.
19. Garcia-Bailo, B., El-Sohemy, A., Haddad, P.S., et al,. (2011) Vitamins D, C and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress. Biologics, 5, 7-19.
20. Vitoratos, N., Dimitrakaki, A., Vlahos, N.F., et al,. (2010) Maternal and umbilical resistin levels do not correlate with infant birth weight either in normal pregnancies and or in pregnancies complicated with gestational diabetes. Journal of Maternal Fetal and Neonatal Medicine, 23, 1019-1023.
21. Pirc, L.K., Owens, J.A., Crowther, C.A., et al,. (2007) Mild gestational diabetes in pregnancy and the adipoinsular axis in babies born to mother in the ACHOIS randomised controlled trial. BMC Pediatrics, 12, 18.
22. Mestan, K., Ouyang, F., Matoba, N., et al,. (2012) Maternal obesity, diabetes mellitus and cord blood biomarkers in large-for-gestational age infants. Journal of Pediatric Biochemistry, 1, 217-224.
23. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. (2008) Canadian Diabetes Association 2008 Clinical Practice Guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes, 32 (Suppl 1), S168-S180.
24. Hanley, A.J.G., Wagenknecht, L.E., Norris, J.M., et al,. (2011) Adiponectin and the incidence of Type 2 diabetes in Hispanics and African Americans. The IRAS Family Study. Diabetes Care, 34, 2231-2236.
25. Vrachnis, N., Belitsos, P., Sifakis, S., et al,. (2012) Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. International Journal of Endocrinology, 2012, doi: 10.1155/2012/549748.
26. Lowe, L.P., Metzger, B.E., Lowe, W.L.J.R., et al,. (2010) Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Journal of Clinical Endocrinology and Metabolism, 95, 5427-5434.
27. Miehle, K., Stepan, H., &, Fasshauer, M., (2012) Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clinical Endocrinology, 76, 2-11.
28. Lobo, T.F., Torloni, M.R., Gueuvoghlanian-Silva, B.Y., et al,. (2013) Resistin concentration and gestational diabetes: a systematic review of the literature. Journal of Reproductive Immunology, 97, 120-127.
29. Anubhuti, S., &, Arora, S., (2008) Leptin and its metabolic interactions: an update. Diabetes, Obesity & Metabolism, 10, 973-993.
30. Lumeng, C.N., &, Saltiel, A.R., (2011) Inflammatory links between obesity and metabolic disease. Journal of Clinical Investigation, 121, 2111-2117.
31. Kajantie, E., Hytinantti, T., Hovi, P., et al,. (2004) Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term. Journal of Clinical Endocrinology and Metabolism, 89, 4031-4036.
32. Ogland, B., Romundstad, P.R., Vefring, H., et al,. (2010) Preeclampsia and adiponectin in cord blood. Hormone Research in Paediatrics, 74, 92-97.
33. Wang, J., Wang, S.H., Shang, L.X., et al,. (2010) Relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia. Journal of Obstetrics Gynaecology Research, 36, 533-537.
34. Saito, M., Nishimura, K., Nozue, H., et al,. (2011) Changes in serum adiponectin levels from birth to term-equivalent age are associated with postnatal weight gain in preterm infants. Neonatology, 100, 93-98.
35. Camargo, C.A. Jr, Ingham, T., Wickens, K., et al,. (2010) Vitamin D status of newborns in New Zealand. British Journal of Nutrition, 104, 1051-1057.